CTNM
Contineum Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.79
+1.03%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.28x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- 0.96x
Liquidity & coverage
- Current ratio
- 31.11x
- Quick ratio
- 31.11x
- Cash ratio
- 30.45x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $241.7M
Cash & dividend
- FCF / debt
- -8.34x
- Cash flow / debt
- -8.28x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026